Bone loss in adults with cystic fibrosis: Prevalence, associated factors, and usefulness of biological markers

Joint Bone Spine

Volumn 79, Issue 1, 2012, Pages 73-77

  Legroux Gérot, Isabelle ^a   Leroy, Sylvie ^a   Prudhomme, Caroline ^a   Perez, Thierry ^a   Flipo, René Marc ^a   Wallaert, Benoît ^a   Cortet, Bernard ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Bone turnover markers; Cystic fibrosis; Osteopenia; Osteoporosis

Indexed keywords

BIOLOGICAL MARKER; GLUCOCORTICOID; ORAL CONTRACEPTIVE AGENT; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FEMUR NECK; FRACTURE; GENE MUTATION; GRIP STRENGTH; HIP; HUMAN; INFLAMMATION; LUMBAR SPINE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PROSPECTIVE STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; COMORBIDITY; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; EXERCISE TEST; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; YOUNG ADULT;

EID: 84855702423     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.05.009     Document Type: Article

References (24)

1. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
2. Haworth C.S., Selby P.L., Webb A.K., et al. E. Low bone mineral density in adults with cystic fibrosis. Thorax 1999, 54:961-967.
3. Rossini M., Del Marco A., Dal Santo F., et al. Prevalence and correlates of vertebral fractures in adults with cystic fibrosis. Bone 2004, 35:771-776.
4. Paccou J., Zeboulon N., Combescure C., et al. The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int 2010, 86:1-7.
5. Conway S.P., Morton A.M., Oldroyd B., et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000, 55:798-804.
6. Aris R.M., Renner J.B., Winders A.D., et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998, 128:186-193.
7. Stephenson A., Jamal S., Dowdell T., et al. Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest 2006, 130:539-544.
8. Hall W.B., Sparks A.A., Aris R.M. Vitamin D deficiency in cystic fibrosis. Int J Endocrinol 2010, 2010:218691.
9. Wolfenden L.L., Judd S.E., Shah R., et al. Vitamin D and bone health in adults with cystic fibrosis. Clinical Endorinol 2008, 69:374-381.
10. Aris R.M., Merkel P.A., Bachrach L.K., et al. Consensus statement: guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005, 90:1888-1896.
11. Laursen E.M., Molgaard C., Michaelsen K.F., et al. Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 1999, 81:235-240.
12. Buntain H.M., Greer R.M., Schulter P.J., et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004, 59:149-155.
13. Haaber A.B., Rosenfalck A.M., Hansen B., et al. Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int J Pancreatol 2000, 27:21-27.
14. Moran C.E., Sosa E.G., Martinez S.M., et al. Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 1997, 92:867-871.
15. Bianchi M.L., Romano G., Saraifoger S., et al. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 2006, 21:388-396.
16. Steinkamp G., Wiedemann Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA). Thorax 2002, 57:596-601. on behalf of the German CFQA Group.
17. Frangolias D.D., Pare P.D., Kendler D.L., et al. Role of exercise and nutrition status on bone mineral density in cystic fibrosis. J Cyst Fibros 2003, 2:163-170.
18. King S.J., Topliss D.J., Kotsimbos T., et al. Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor. Eur Respir J 2005, 25:54-61.
19. Shead E.F., Haworth C.S., Condliffe A.M., et al. Cystic fibrosis transmembrane conductance regular (CFTR) is expressed in human bone. Thorax 2007, 62:650-651.
20. Haworth C.S., Selby P.L., Webb A.K., et al. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 2004, 59:613-617.
21. Ionescu A.A., Nixon L.S., Evans W.D., et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000, 162:789-794.
22. Shead E.F., Haworth C.S., Barker H., et al. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros 2010, 9:93-98.
23. Javier RM, Jacquot J. Bone disease in cystic fibrosis: What's new? Joint Bone Spine 2011: doi:10.1016/j.jbspin.2010.11.015.
24. Sermet-Gaudelus I., Munck A., Rota M., et al. French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening. Arch Pediatr 2010, 17:1349-1358. [In French].